nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—SLCO1B3—Rosuvastatin—atherosclerosis	0.0551	0.0809	CbGbCtD
Paclitaxel—ABCB11—Rosuvastatin—atherosclerosis	0.0536	0.0787	CbGbCtD
Paclitaxel—SLCO1B3—Pravastatin—atherosclerosis	0.0501	0.0736	CbGbCtD
Paclitaxel—ABCB11—Pravastatin—atherosclerosis	0.0488	0.0716	CbGbCtD
Paclitaxel—ABCC1—Rosuvastatin—atherosclerosis	0.0381	0.0559	CbGbCtD
Paclitaxel—ABCC2—Ezetimibe—atherosclerosis	0.0282	0.0414	CbGbCtD
Paclitaxel—ABCC2—Simvastatin—atherosclerosis	0.0262	0.0385	CbGbCtD
Paclitaxel—ABCC2—Pravastatin—atherosclerosis	0.0257	0.0377	CbGbCtD
Paclitaxel—ABCC2—Lovastatin—atherosclerosis	0.0257	0.0377	CbGbCtD
Paclitaxel—ABCG2—Rosuvastatin—atherosclerosis	0.0255	0.0374	CbGbCtD
Paclitaxel—ABCG2—Ezetimibe—atherosclerosis	0.0255	0.0374	CbGbCtD
Paclitaxel—ABCG2—Pravastatin—atherosclerosis	0.0232	0.034	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0175	0.0257	CbGbCtD
Paclitaxel—CYP3A7—Simvastatin—atherosclerosis	0.0175	0.0257	CbGbCtD
Paclitaxel—CYP3A7—Lovastatin—atherosclerosis	0.0171	0.0251	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0171	0.0251	CbGbCtD
Paclitaxel—CYP3A5—Rosuvastatin—atherosclerosis	0.0141	0.0207	CbGbCtD
Paclitaxel—CYP3A5—Simvastatin—atherosclerosis	0.0131	0.0193	CbGbCtD
Paclitaxel—CYP3A5—Lovastatin—atherosclerosis	0.0129	0.0189	CbGbCtD
Paclitaxel—CYP3A5—Pravastatin—atherosclerosis	0.0129	0.0189	CbGbCtD
Paclitaxel—CYP2C8—Simvastatin—atherosclerosis	0.0126	0.0185	CbGbCtD
Paclitaxel—CYP2C8—Lovastatin—atherosclerosis	0.0124	0.0181	CbGbCtD
Paclitaxel—CYP2C8—Pravastatin—atherosclerosis	0.0124	0.0181	CbGbCtD
Paclitaxel—MAP2—middle cerebral artery—atherosclerosis	0.0119	0.275	CbGeAlD
Paclitaxel—CYP2C9—Rosuvastatin—atherosclerosis	0.00947	0.0139	CbGbCtD
Paclitaxel—ABCB1—Ezetimibe—atherosclerosis	0.00919	0.0135	CbGbCtD
Paclitaxel—CYP2C9—Simvastatin—atherosclerosis	0.00881	0.0129	CbGbCtD
Paclitaxel—CYP2C9—Pravastatin—atherosclerosis	0.00862	0.0126	CbGbCtD
Paclitaxel—CYP2C9—Lovastatin—atherosclerosis	0.00862	0.0126	CbGbCtD
Paclitaxel—ABCB1—Simvastatin—atherosclerosis	0.00855	0.0125	CbGbCtD
Paclitaxel—ABCB1—Pravastatin—atherosclerosis	0.00837	0.0123	CbGbCtD
Paclitaxel—ABCB1—Lovastatin—atherosclerosis	0.00837	0.0123	CbGbCtD
Paclitaxel—CYP3A4—Ezetimibe—atherosclerosis	0.00551	0.00808	CbGbCtD
Paclitaxel—CYP3A4—Rosuvastatin—atherosclerosis	0.00551	0.00808	CbGbCtD
Paclitaxel—CYP3A4—Simvastatin—atherosclerosis	0.00512	0.00752	CbGbCtD
Paclitaxel—CYP3A4—Lovastatin—atherosclerosis	0.00501	0.00735	CbGbCtD
Paclitaxel—CYP3A4—Pravastatin—atherosclerosis	0.00501	0.00735	CbGbCtD
Paclitaxel—TUBB3—connective tissue—atherosclerosis	0.00129	0.0299	CbGeAlD
Paclitaxel—MAP4—connective tissue—atherosclerosis	0.00129	0.0299	CbGeAlD
Paclitaxel—MAPT—adipose tissue—atherosclerosis	0.00126	0.0292	CbGeAlD
Paclitaxel—BCL2—connective tissue—atherosclerosis	0.00117	0.0272	CbGeAlD
Paclitaxel—MAP4—cardiovascular system—atherosclerosis	0.00112	0.026	CbGeAlD
Paclitaxel—NR1I2—liver—atherosclerosis	0.00106	0.0246	CbGeAlD
Paclitaxel—BCL2—cardiovascular system—atherosclerosis	0.00102	0.0236	CbGeAlD
Paclitaxel—MAP4—adipose tissue—atherosclerosis	0.000988	0.0229	CbGeAlD
Paclitaxel—TUBB1—adipose tissue—atherosclerosis	0.000966	0.0224	CbGeAlD
Paclitaxel—TUBB6—Pimozide—Ezetimibe—atherosclerosis	0.000959	0.288	CbGdCrCtD
Paclitaxel—MAP2—cardiovascular system—atherosclerosis	0.000882	0.0205	CbGeAlD
Paclitaxel—TUBB6—Fluvastatin—Rosuvastatin—atherosclerosis	0.000814	0.244	CbGdCrCtD
Paclitaxel—TUBB4A—connective tissue—atherosclerosis	0.000784	0.0182	CbGeAlD
Paclitaxel—TUBB6—Simvastatin—Lovastatin—atherosclerosis	0.000779	0.234	CbGdCrCtD
Paclitaxel—TUBB6—Simvastatin—Pravastatin—atherosclerosis	0.000779	0.234	CbGdCrCtD
Paclitaxel—MAP2—adipose tissue—atherosclerosis	0.000778	0.0181	CbGeAlD
Paclitaxel—TUBB2B—connective tissue—atherosclerosis	0.000757	0.0176	CbGeAlD
Paclitaxel—TUBB2A—connective tissue—atherosclerosis	0.000713	0.0165	CbGeAlD
Paclitaxel—MAP4—liver—atherosclerosis	0.000693	0.0161	CbGeAlD
Paclitaxel—TUBB4A—cardiovascular system—atherosclerosis	0.000682	0.0158	CbGeAlD
Paclitaxel—TUBB6—cardiovascular system—atherosclerosis	0.000612	0.0142	CbGeAlD
Paclitaxel—TUBB4B—connective tissue—atherosclerosis	0.000611	0.0142	CbGeAlD
Paclitaxel—SLCO1B3—liver—atherosclerosis	0.000607	0.0141	CbGeAlD
Paclitaxel—TUBB2B—adipose tissue—atherosclerosis	0.000581	0.0135	CbGeAlD
Paclitaxel—TUBB—adipose tissue—atherosclerosis	0.00055	0.0128	CbGeAlD
Paclitaxel—TUBB2A—adipose tissue—atherosclerosis	0.000547	0.0127	CbGeAlD
Paclitaxel—MAP2—liver—atherosclerosis	0.000546	0.0127	CbGeAlD
Paclitaxel—TUBB6—adipose tissue—atherosclerosis	0.000539	0.0125	CbGeAlD
Paclitaxel—TUBB4B—cardiovascular system—atherosclerosis	0.000532	0.0123	CbGeAlD
Paclitaxel—ABCB11—liver—atherosclerosis	0.000523	0.0121	CbGeAlD
Paclitaxel—CYP19A1—connective tissue—atherosclerosis	0.000518	0.012	CbGeAlD
Paclitaxel—CYP3A7—liver—atherosclerosis	0.000512	0.0119	CbGeAlD
Paclitaxel—CYP1B1—connective tissue—atherosclerosis	0.000484	0.0112	CbGeAlD
Paclitaxel—ABCC10—adipose tissue—atherosclerosis	0.000472	0.011	CbGeAlD
Paclitaxel—TUBB4B—adipose tissue—atherosclerosis	0.000469	0.0109	CbGeAlD
Paclitaxel—CYP3A7-CYP3A51P—liver—atherosclerosis	0.000435	0.0101	CbGeAlD
Paclitaxel—TUBB4A—liver—atherosclerosis	0.000422	0.00979	CbGeAlD
Paclitaxel—CYP1B1—cardiovascular system—atherosclerosis	0.000421	0.00978	CbGeAlD
Paclitaxel—CYP19A1—adipose tissue—atherosclerosis	0.000397	0.00922	CbGeAlD
Paclitaxel—TUBB—liver—atherosclerosis	0.000386	0.00895	CbGeAlD
Paclitaxel—TUBB2A—liver—atherosclerosis	0.000384	0.0089	CbGeAlD
Paclitaxel—TUBB6—liver—atherosclerosis	0.000378	0.00878	CbGeAlD
Paclitaxel—CYP1B1—adipose tissue—atherosclerosis	0.000371	0.00862	CbGeAlD
Paclitaxel—ABCB1—blood vessel—atherosclerosis	0.000347	0.00805	CbGeAlD
Paclitaxel—ABCC1—adipose tissue—atherosclerosis	0.000334	0.00776	CbGeAlD
Paclitaxel—ABCC10—liver—atherosclerosis	0.000331	0.00769	CbGeAlD
Paclitaxel—TUBB4B—liver—atherosclerosis	0.000329	0.00763	CbGeAlD
Paclitaxel—CYP2C9—cardiovascular system—atherosclerosis	0.000287	0.00665	CbGeAlD
Paclitaxel—CYP19A1—liver—atherosclerosis	0.000279	0.00647	CbGeAlD
Paclitaxel—ABCG2—adipose tissue—atherosclerosis	0.000277	0.00642	CbGeAlD
Paclitaxel—ABCC2—liver—atherosclerosis	0.000266	0.00617	CbGeAlD
Paclitaxel—CYP1B1—liver—atherosclerosis	0.00026	0.00605	CbGeAlD
Paclitaxel—CYP3A5—adipose tissue—atherosclerosis	0.000257	0.00596	CbGeAlD
Paclitaxel—ABCC1—liver—atherosclerosis	0.000234	0.00544	CbGeAlD
Paclitaxel—Muscle spasms—Simvastatin—atherosclerosis	0.000221	0.00146	CcSEcCtD
Paclitaxel—Vertigo—Lovastatin—atherosclerosis	0.000221	0.00146	CcSEcCtD
Paclitaxel—Angioedema—Ezetimibe—atherosclerosis	0.000221	0.00146	CcSEcCtD
Paclitaxel—Angiopathy—Niacin—atherosclerosis	0.00022	0.00146	CcSEcCtD
Paclitaxel—Leukopenia—Lovastatin—atherosclerosis	0.00022	0.00146	CcSEcCtD
Paclitaxel—Chills—Niacin—atherosclerosis	0.000218	0.00144	CcSEcCtD
Paclitaxel—Malaise—Ezetimibe—atherosclerosis	0.000218	0.00144	CcSEcCtD
Paclitaxel—Vision blurred—Simvastatin—atherosclerosis	0.000217	0.00144	CcSEcCtD
Paclitaxel—Arrhythmia—Niacin—atherosclerosis	0.000217	0.00144	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000216	0.00143	CcSEcCtD
Paclitaxel—Tremor—Simvastatin—atherosclerosis	0.000216	0.00143	CcSEcCtD
Paclitaxel—Alopecia—Niacin—atherosclerosis	0.000215	0.00142	CcSEcCtD
Paclitaxel—Chills—Pravastatin—atherosclerosis	0.000215	0.00142	CcSEcCtD
Paclitaxel—Insomnia—Rosuvastatin—atherosclerosis	0.000214	0.00142	CcSEcCtD
Paclitaxel—Ill-defined disorder—Simvastatin—atherosclerosis	0.000214	0.00141	CcSEcCtD
Paclitaxel—Arrhythmia—Pravastatin—atherosclerosis	0.000214	0.00141	CcSEcCtD
Paclitaxel—Palpitations—Ezetimibe—atherosclerosis	0.000213	0.00141	CcSEcCtD
Paclitaxel—Paraesthesia—Rosuvastatin—atherosclerosis	0.000213	0.00141	CcSEcCtD
Paclitaxel—Anaemia—Simvastatin—atherosclerosis	0.000213	0.00141	CcSEcCtD
Paclitaxel—Malnutrition—Niacin—atherosclerosis	0.000211	0.0014	CcSEcCtD
Paclitaxel—Erythema—Niacin—atherosclerosis	0.000211	0.0014	CcSEcCtD
Paclitaxel—Alopecia—Pravastatin—atherosclerosis	0.000211	0.0014	CcSEcCtD
Paclitaxel—Cough—Ezetimibe—atherosclerosis	0.000211	0.00139	CcSEcCtD
Paclitaxel—Angioedema—Simvastatin—atherosclerosis	0.00021	0.00139	CcSEcCtD
Paclitaxel—Arthralgia—Lovastatin—atherosclerosis	0.00021	0.00139	CcSEcCtD
Paclitaxel—Chest pain—Lovastatin—atherosclerosis	0.00021	0.00139	CcSEcCtD
Paclitaxel—Myalgia—Lovastatin—atherosclerosis	0.00021	0.00139	CcSEcCtD
Paclitaxel—Anxiety—Lovastatin—atherosclerosis	0.000209	0.00138	CcSEcCtD
Paclitaxel—Dyspepsia—Rosuvastatin—atherosclerosis	0.000209	0.00138	CcSEcCtD
Paclitaxel—Hypertension—Ezetimibe—atherosclerosis	0.000209	0.00138	CcSEcCtD
Paclitaxel—Flatulence—Niacin—atherosclerosis	0.000208	0.00138	CcSEcCtD
Paclitaxel—Malaise—Simvastatin—atherosclerosis	0.000208	0.00137	CcSEcCtD
Paclitaxel—Tension—Niacin—atherosclerosis	0.000208	0.00137	CcSEcCtD
Paclitaxel—Discomfort—Lovastatin—atherosclerosis	0.000207	0.00137	CcSEcCtD
Paclitaxel—Vertigo—Simvastatin—atherosclerosis	0.000207	0.00137	CcSEcCtD
Paclitaxel—Leukopenia—Simvastatin—atherosclerosis	0.000206	0.00136	CcSEcCtD
Paclitaxel—Chest pain—Ezetimibe—atherosclerosis	0.000206	0.00136	CcSEcCtD
Paclitaxel—Arthralgia—Ezetimibe—atherosclerosis	0.000206	0.00136	CcSEcCtD
Paclitaxel—Myalgia—Ezetimibe—atherosclerosis	0.000206	0.00136	CcSEcCtD
Paclitaxel—Nervousness—Niacin—atherosclerosis	0.000205	0.00136	CcSEcCtD
Paclitaxel—Flatulence—Pravastatin—atherosclerosis	0.000205	0.00136	CcSEcCtD
Paclitaxel—Dry mouth—Lovastatin—atherosclerosis	0.000205	0.00136	CcSEcCtD
Paclitaxel—Tension—Pravastatin—atherosclerosis	0.000204	0.00135	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000204	0.00135	CcSEcCtD
Paclitaxel—Dysgeusia—Pravastatin—atherosclerosis	0.000204	0.00135	CcSEcCtD
Paclitaxel—Muscle spasms—Niacin—atherosclerosis	0.000203	0.00134	CcSEcCtD
Paclitaxel—Discomfort—Ezetimibe—atherosclerosis	0.000203	0.00134	CcSEcCtD
Paclitaxel—Pain—Rosuvastatin—atherosclerosis	0.000203	0.00134	CcSEcCtD
Paclitaxel—Constipation—Rosuvastatin—atherosclerosis	0.000203	0.00134	CcSEcCtD
Paclitaxel—Confusional state—Lovastatin—atherosclerosis	0.000203	0.00134	CcSEcCtD
Paclitaxel—Nervousness—Pravastatin—atherosclerosis	0.000202	0.00134	CcSEcCtD
Paclitaxel—Dry mouth—Ezetimibe—atherosclerosis	0.000201	0.00133	CcSEcCtD
Paclitaxel—Anaphylactic shock—Lovastatin—atherosclerosis	0.000201	0.00133	CcSEcCtD
Paclitaxel—Muscle spasms—Pravastatin—atherosclerosis	0.0002	0.00132	CcSEcCtD
Paclitaxel—Infection—Lovastatin—atherosclerosis	0.0002	0.00132	CcSEcCtD
Paclitaxel—CYP2C8—liver—atherosclerosis	0.000199	0.00463	CbGeAlD
Paclitaxel—Vision blurred—Niacin—atherosclerosis	0.000199	0.00132	CcSEcCtD
Paclitaxel—Confusional state—Ezetimibe—atherosclerosis	0.000199	0.00131	CcSEcCtD
Paclitaxel—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000197	0.0013	CcSEcCtD
Paclitaxel—Thrombocytopenia—Lovastatin—atherosclerosis	0.000197	0.0013	CcSEcCtD
Paclitaxel—Vision blurred—Pravastatin—atherosclerosis	0.000196	0.0013	CcSEcCtD
Paclitaxel—Myalgia—Simvastatin—atherosclerosis	0.000196	0.0013	CcSEcCtD
Paclitaxel—Chest pain—Simvastatin—atherosclerosis	0.000196	0.0013	CcSEcCtD
Paclitaxel—Arthralgia—Simvastatin—atherosclerosis	0.000196	0.0013	CcSEcCtD
Paclitaxel—Infection—Ezetimibe—atherosclerosis	0.000196	0.0013	CcSEcCtD
Paclitaxel—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000195	0.00129	CcSEcCtD
Paclitaxel—Anxiety—Simvastatin—atherosclerosis	0.000195	0.00129	CcSEcCtD
Paclitaxel—Tremor—Pravastatin—atherosclerosis	0.000195	0.00129	CcSEcCtD
Paclitaxel—ABCG2—liver—atherosclerosis	0.000194	0.0045	CbGeAlD
Paclitaxel—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000194	0.00128	CcSEcCtD
Paclitaxel—Discomfort—Simvastatin—atherosclerosis	0.000194	0.00128	CcSEcCtD
Paclitaxel—Nervous system disorder—Ezetimibe—atherosclerosis	0.000193	0.00128	CcSEcCtD
Paclitaxel—Angioedema—Niacin—atherosclerosis	0.000193	0.00128	CcSEcCtD
Paclitaxel—Ill-defined disorder—Pravastatin—atherosclerosis	0.000193	0.00128	CcSEcCtD
Paclitaxel—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000193	0.00128	CcSEcCtD
Paclitaxel—Anaemia—Pravastatin—atherosclerosis	0.000192	0.00127	CcSEcCtD
Paclitaxel—Anorexia—Lovastatin—atherosclerosis	0.000192	0.00127	CcSEcCtD
Paclitaxel—Skin disorder—Ezetimibe—atherosclerosis	0.000191	0.00127	CcSEcCtD
Paclitaxel—Angioedema—Pravastatin—atherosclerosis	0.00019	0.00126	CcSEcCtD
Paclitaxel—Vertigo—Niacin—atherosclerosis	0.00019	0.00126	CcSEcCtD
Paclitaxel—Syncope—Niacin—atherosclerosis	0.00019	0.00125	CcSEcCtD
Paclitaxel—Confusional state—Simvastatin—atherosclerosis	0.00019	0.00125	CcSEcCtD
Paclitaxel—Leukopenia—Niacin—atherosclerosis	0.000189	0.00125	CcSEcCtD
Paclitaxel—Urticaria—Rosuvastatin—atherosclerosis	0.000188	0.00125	CcSEcCtD
Paclitaxel—Anaphylactic shock—Simvastatin—atherosclerosis	0.000188	0.00124	CcSEcCtD
Paclitaxel—Oedema—Simvastatin—atherosclerosis	0.000188	0.00124	CcSEcCtD
Paclitaxel—Malaise—Pravastatin—atherosclerosis	0.000188	0.00124	CcSEcCtD
Paclitaxel—Abdominal pain—Rosuvastatin—atherosclerosis	0.000187	0.00124	CcSEcCtD
Paclitaxel—Vertigo—Pravastatin—atherosclerosis	0.000187	0.00124	CcSEcCtD
Paclitaxel—Palpitations—Niacin—atherosclerosis	0.000187	0.00124	CcSEcCtD
Paclitaxel—Infection—Simvastatin—atherosclerosis	0.000187	0.00124	CcSEcCtD
Paclitaxel—Leukopenia—Pravastatin—atherosclerosis	0.000186	0.00123	CcSEcCtD
Paclitaxel—Loss of consciousness—Niacin—atherosclerosis	0.000186	0.00123	CcSEcCtD
Paclitaxel—Cough—Niacin—atherosclerosis	0.000185	0.00122	CcSEcCtD
Paclitaxel—Thrombocytopenia—Simvastatin—atherosclerosis	0.000184	0.00122	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000183	0.00121	CcSEcCtD
Paclitaxel—Insomnia—Lovastatin—atherosclerosis	0.000182	0.0012	CcSEcCtD
Paclitaxel—Cough—Pravastatin—atherosclerosis	0.000182	0.0012	CcSEcCtD
Paclitaxel—Paraesthesia—Lovastatin—atherosclerosis	0.00018	0.00119	CcSEcCtD
Paclitaxel—Myalgia—Niacin—atherosclerosis	0.00018	0.00119	CcSEcCtD
Paclitaxel—Arthralgia—Niacin—atherosclerosis	0.00018	0.00119	CcSEcCtD
Paclitaxel—CYP3A5—liver—atherosclerosis	0.00018	0.00418	CbGeAlD
Paclitaxel—Hypertension—Pravastatin—atherosclerosis	0.00018	0.00119	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00018	0.00119	CcSEcCtD
Paclitaxel—Anorexia—Simvastatin—atherosclerosis	0.000179	0.00119	CcSEcCtD
Paclitaxel—Dyspnoea—Lovastatin—atherosclerosis	0.000179	0.00119	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000179	0.00118	CcSEcCtD
Paclitaxel—Insomnia—Ezetimibe—atherosclerosis	0.000178	0.00118	CcSEcCtD
Paclitaxel—Myalgia—Pravastatin—atherosclerosis	0.000177	0.00117	CcSEcCtD
Paclitaxel—Chest pain—Pravastatin—atherosclerosis	0.000177	0.00117	CcSEcCtD
Paclitaxel—Arthralgia—Pravastatin—atherosclerosis	0.000177	0.00117	CcSEcCtD
Paclitaxel—CYP2C9—liver—atherosclerosis	0.000177	0.00411	CbGeAlD
Paclitaxel—Paraesthesia—Ezetimibe—atherosclerosis	0.000177	0.00117	CcSEcCtD
Paclitaxel—Dyspepsia—Lovastatin—atherosclerosis	0.000177	0.00117	CcSEcCtD
Paclitaxel—Anxiety—Pravastatin—atherosclerosis	0.000177	0.00117	CcSEcCtD
Paclitaxel—Dry mouth—Niacin—atherosclerosis	0.000176	0.00116	CcSEcCtD
Paclitaxel—Dyspnoea—Ezetimibe—atherosclerosis	0.000176	0.00116	CcSEcCtD
Paclitaxel—Discomfort—Pravastatin—atherosclerosis	0.000175	0.00116	CcSEcCtD
Paclitaxel—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000175	0.00116	CcSEcCtD
Paclitaxel—Decreased appetite—Lovastatin—atherosclerosis	0.000175	0.00116	CcSEcCtD
Paclitaxel—Dyspepsia—Ezetimibe—atherosclerosis	0.000174	0.00115	CcSEcCtD
Paclitaxel—Fatigue—Lovastatin—atherosclerosis	0.000173	0.00115	CcSEcCtD
Paclitaxel—Oedema—Niacin—atherosclerosis	0.000173	0.00114	CcSEcCtD
Paclitaxel—Anaphylactic shock—Niacin—atherosclerosis	0.000173	0.00114	CcSEcCtD
Paclitaxel—Pain—Lovastatin—atherosclerosis	0.000172	0.00114	CcSEcCtD
Paclitaxel—Constipation—Lovastatin—atherosclerosis	0.000172	0.00114	CcSEcCtD
Paclitaxel—Confusional state—Pravastatin—atherosclerosis	0.000171	0.00113	CcSEcCtD
Paclitaxel—Decreased appetite—Ezetimibe—atherosclerosis	0.000171	0.00113	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000171	0.00113	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00017	0.00113	CcSEcCtD
Paclitaxel—Asthenia—Rosuvastatin—atherosclerosis	0.00017	0.00113	CcSEcCtD
Paclitaxel—Insomnia—Simvastatin—atherosclerosis	0.00017	0.00112	CcSEcCtD
Paclitaxel—Anaphylactic shock—Pravastatin—atherosclerosis	0.00017	0.00112	CcSEcCtD
Paclitaxel—Oedema—Pravastatin—atherosclerosis	0.00017	0.00112	CcSEcCtD
Paclitaxel—Fatigue—Ezetimibe—atherosclerosis	0.00017	0.00112	CcSEcCtD
Paclitaxel—Shock—Niacin—atherosclerosis	0.00017	0.00112	CcSEcCtD
Paclitaxel—Infection—Pravastatin—atherosclerosis	0.000169	0.00112	CcSEcCtD
Paclitaxel—Paraesthesia—Simvastatin—atherosclerosis	0.000169	0.00112	CcSEcCtD
Paclitaxel—Constipation—Ezetimibe—atherosclerosis	0.000169	0.00111	CcSEcCtD
Paclitaxel—Pain—Ezetimibe—atherosclerosis	0.000169	0.00111	CcSEcCtD
Paclitaxel—Tachycardia—Niacin—atherosclerosis	0.000168	0.00111	CcSEcCtD
Paclitaxel—Pruritus—Rosuvastatin—atherosclerosis	0.000168	0.00111	CcSEcCtD
Paclitaxel—Skin disorder—Niacin—atherosclerosis	0.000168	0.00111	CcSEcCtD
Paclitaxel—Dyspnoea—Simvastatin—atherosclerosis	0.000168	0.00111	CcSEcCtD
Paclitaxel—Hyperhidrosis—Niacin—atherosclerosis	0.000167	0.0011	CcSEcCtD
Paclitaxel—Thrombocytopenia—Pravastatin—atherosclerosis	0.000166	0.0011	CcSEcCtD
Paclitaxel—Feeling abnormal—Lovastatin—atherosclerosis	0.000166	0.0011	CcSEcCtD
Paclitaxel—Dyspepsia—Simvastatin—atherosclerosis	0.000165	0.00109	CcSEcCtD
Paclitaxel—Anorexia—Niacin—atherosclerosis	0.000165	0.00109	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000164	0.00109	CcSEcCtD
Paclitaxel—Hyperhidrosis—Pravastatin—atherosclerosis	0.000164	0.00109	CcSEcCtD
Paclitaxel—Decreased appetite—Simvastatin—atherosclerosis	0.000163	0.00108	CcSEcCtD
Paclitaxel—Feeling abnormal—Ezetimibe—atherosclerosis	0.000162	0.00107	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000162	0.00107	CcSEcCtD
Paclitaxel—Diarrhoea—Rosuvastatin—atherosclerosis	0.000162	0.00107	CcSEcCtD
Paclitaxel—Fatigue—Simvastatin—atherosclerosis	0.000162	0.00107	CcSEcCtD
Paclitaxel—Anorexia—Pravastatin—atherosclerosis	0.000162	0.00107	CcSEcCtD
Paclitaxel—Hypotension—Niacin—atherosclerosis	0.000161	0.00107	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000161	0.00107	CcSEcCtD
Paclitaxel—Pain—Simvastatin—atherosclerosis	0.000161	0.00106	CcSEcCtD
Paclitaxel—Constipation—Simvastatin—atherosclerosis	0.000161	0.00106	CcSEcCtD
Paclitaxel—Urticaria—Lovastatin—atherosclerosis	0.00016	0.00106	CcSEcCtD
Paclitaxel—Abdominal pain—Lovastatin—atherosclerosis	0.000159	0.00105	CcSEcCtD
Paclitaxel—Body temperature increased—Lovastatin—atherosclerosis	0.000159	0.00105	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000157	0.00104	CcSEcCtD
Paclitaxel—Dizziness—Rosuvastatin—atherosclerosis	0.000157	0.00104	CcSEcCtD
Paclitaxel—Urticaria—Ezetimibe—atherosclerosis	0.000157	0.00104	CcSEcCtD
Paclitaxel—Insomnia—Niacin—atherosclerosis	0.000156	0.00103	CcSEcCtD
Paclitaxel—Abdominal pain—Ezetimibe—atherosclerosis	0.000156	0.00103	CcSEcCtD
Paclitaxel—Body temperature increased—Ezetimibe—atherosclerosis	0.000156	0.00103	CcSEcCtD
Paclitaxel—Paraesthesia—Niacin—atherosclerosis	0.000155	0.00103	CcSEcCtD
Paclitaxel—Feeling abnormal—Simvastatin—atherosclerosis	0.000155	0.00102	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000155	0.00102	CcSEcCtD
Paclitaxel—ABCB1—cardiovascular system—atherosclerosis	0.000155	0.00359	CbGeAlD
Paclitaxel—Dyspnoea—Niacin—atherosclerosis	0.000154	0.00102	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000154	0.00102	CcSEcCtD
Paclitaxel—Insomnia—Pravastatin—atherosclerosis	0.000154	0.00102	CcSEcCtD
Paclitaxel—Somnolence—Niacin—atherosclerosis	0.000153	0.00101	CcSEcCtD
Paclitaxel—Paraesthesia—Pravastatin—atherosclerosis	0.000153	0.00101	CcSEcCtD
Paclitaxel—Dyspepsia—Niacin—atherosclerosis	0.000152	0.001	CcSEcCtD
Paclitaxel—Dyspnoea—Pravastatin—atherosclerosis	0.000152	0.001	CcSEcCtD
Paclitaxel—Decreased appetite—Niacin—atherosclerosis	0.00015	0.000992	CcSEcCtD
Paclitaxel—Dyspepsia—Pravastatin—atherosclerosis	0.00015	0.000989	CcSEcCtD
Paclitaxel—Rash—Rosuvastatin—atherosclerosis	0.00015	0.000989	CcSEcCtD
Paclitaxel—Dermatitis—Rosuvastatin—atherosclerosis	0.000149	0.000988	CcSEcCtD
Paclitaxel—Urticaria—Simvastatin—atherosclerosis	0.000149	0.000988	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Niacin—atherosclerosis	0.000149	0.000986	CcSEcCtD
Paclitaxel—Body temperature increased—Simvastatin—atherosclerosis	0.000149	0.000983	CcSEcCtD
Paclitaxel—Abdominal pain—Simvastatin—atherosclerosis	0.000149	0.000983	CcSEcCtD
Paclitaxel—Headache—Rosuvastatin—atherosclerosis	0.000149	0.000983	CcSEcCtD
Paclitaxel—Hypersensitivity—Lovastatin—atherosclerosis	0.000148	0.000979	CcSEcCtD
Paclitaxel—Decreased appetite—Pravastatin—atherosclerosis	0.000148	0.000977	CcSEcCtD
Paclitaxel—Pain—Niacin—atherosclerosis	0.000148	0.000976	CcSEcCtD
Paclitaxel—Fatigue—Pravastatin—atherosclerosis	0.000147	0.000969	CcSEcCtD
Paclitaxel—Constipation—Pravastatin—atherosclerosis	0.000145	0.000961	CcSEcCtD
Paclitaxel—Pain—Pravastatin—atherosclerosis	0.000145	0.000961	CcSEcCtD
Paclitaxel—Hypersensitivity—Ezetimibe—atherosclerosis	0.000145	0.000961	CcSEcCtD
Paclitaxel—Asthenia—Lovastatin—atherosclerosis	0.000144	0.000954	CcSEcCtD
Paclitaxel—Pruritus—Lovastatin—atherosclerosis	0.000142	0.00094	CcSEcCtD
Paclitaxel—Asthenia—Ezetimibe—atherosclerosis	0.000141	0.000935	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Niacin—atherosclerosis	0.000141	0.000934	CcSEcCtD
Paclitaxel—Nausea—Rosuvastatin—atherosclerosis	0.000141	0.000932	CcSEcCtD
Paclitaxel—Feeling abnormal—Pravastatin—atherosclerosis	0.00014	0.000926	CcSEcCtD
Paclitaxel—Pruritus—Ezetimibe—atherosclerosis	0.000139	0.000922	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000139	0.000919	CcSEcCtD
Paclitaxel—Hypersensitivity—Simvastatin—atherosclerosis	0.000138	0.000916	CcSEcCtD
Paclitaxel—Diarrhoea—Lovastatin—atherosclerosis	0.000138	0.000909	CcSEcCtD
Paclitaxel—Urticaria—Niacin—atherosclerosis	0.000137	0.000907	CcSEcCtD
Paclitaxel—Abdominal pain—Niacin—atherosclerosis	0.000136	0.000902	CcSEcCtD
Paclitaxel—Body temperature increased—Niacin—atherosclerosis	0.000136	0.000902	CcSEcCtD
Paclitaxel—ABCB1—adipose tissue—atherosclerosis	0.000136	0.00317	CbGeAlD
Paclitaxel—CYP3A4—liver—atherosclerosis	0.000135	0.00314	CbGeAlD
Paclitaxel—Urticaria—Pravastatin—atherosclerosis	0.000135	0.000893	CcSEcCtD
Paclitaxel—Asthenia—Simvastatin—atherosclerosis	0.000135	0.000892	CcSEcCtD
Paclitaxel—Diarrhoea—Ezetimibe—atherosclerosis	0.000135	0.000892	CcSEcCtD
Paclitaxel—Abdominal pain—Pravastatin—atherosclerosis	0.000134	0.000889	CcSEcCtD
Paclitaxel—Body temperature increased—Pravastatin—atherosclerosis	0.000134	0.000889	CcSEcCtD
Paclitaxel—Pruritus—Simvastatin—atherosclerosis	0.000133	0.00088	CcSEcCtD
Paclitaxel—Dizziness—Lovastatin—atherosclerosis	0.000133	0.000879	CcSEcCtD
Paclitaxel—Dizziness—Ezetimibe—atherosclerosis	0.00013	0.000862	CcSEcCtD
Paclitaxel—Diarrhoea—Simvastatin—atherosclerosis	0.000129	0.000851	CcSEcCtD
Paclitaxel—Vomiting—Lovastatin—atherosclerosis	0.000128	0.000845	CcSEcCtD
Paclitaxel—Hypersensitivity—Niacin—atherosclerosis	0.000127	0.000841	CcSEcCtD
Paclitaxel—Rash—Lovastatin—atherosclerosis	0.000127	0.000838	CcSEcCtD
Paclitaxel—Dermatitis—Lovastatin—atherosclerosis	0.000127	0.000837	CcSEcCtD
Paclitaxel—Headache—Lovastatin—atherosclerosis	0.000126	0.000833	CcSEcCtD
Paclitaxel—Vomiting—Ezetimibe—atherosclerosis	0.000125	0.000829	CcSEcCtD
Paclitaxel—Hypersensitivity—Pravastatin—atherosclerosis	0.000125	0.000828	CcSEcCtD
Paclitaxel—Dizziness—Simvastatin—atherosclerosis	0.000124	0.000822	CcSEcCtD
Paclitaxel—Rash—Ezetimibe—atherosclerosis	0.000124	0.000822	CcSEcCtD
Paclitaxel—Dermatitis—Ezetimibe—atherosclerosis	0.000124	0.000821	CcSEcCtD
Paclitaxel—Asthenia—Niacin—atherosclerosis	0.000124	0.000819	CcSEcCtD
Paclitaxel—Headache—Ezetimibe—atherosclerosis	0.000123	0.000817	CcSEcCtD
Paclitaxel—Pruritus—Niacin—atherosclerosis	0.000122	0.000808	CcSEcCtD
Paclitaxel—Asthenia—Pravastatin—atherosclerosis	0.000122	0.000806	CcSEcCtD
Paclitaxel—Pruritus—Pravastatin—atherosclerosis	0.00012	0.000795	CcSEcCtD
Paclitaxel—Vomiting—Simvastatin—atherosclerosis	0.00012	0.00079	CcSEcCtD
Paclitaxel—Nausea—Lovastatin—atherosclerosis	0.000119	0.00079	CcSEcCtD
Paclitaxel—Rash—Simvastatin—atherosclerosis	0.000119	0.000784	CcSEcCtD
Paclitaxel—Dermatitis—Simvastatin—atherosclerosis	0.000118	0.000783	CcSEcCtD
Paclitaxel—Diarrhoea—Niacin—atherosclerosis	0.000118	0.000781	CcSEcCtD
Paclitaxel—Headache—Simvastatin—atherosclerosis	0.000118	0.000779	CcSEcCtD
Paclitaxel—Nausea—Ezetimibe—atherosclerosis	0.000117	0.000774	CcSEcCtD
Paclitaxel—Diarrhoea—Pravastatin—atherosclerosis	0.000116	0.000769	CcSEcCtD
Paclitaxel—Dizziness—Niacin—atherosclerosis	0.000114	0.000755	CcSEcCtD
Paclitaxel—Dizziness—Pravastatin—atherosclerosis	0.000112	0.000743	CcSEcCtD
Paclitaxel—Nausea—Simvastatin—atherosclerosis	0.000112	0.000738	CcSEcCtD
Paclitaxel—Vomiting—Niacin—atherosclerosis	0.00011	0.000726	CcSEcCtD
Paclitaxel—Rash—Niacin—atherosclerosis	0.000109	0.00072	CcSEcCtD
Paclitaxel—Dermatitis—Niacin—atherosclerosis	0.000109	0.000719	CcSEcCtD
Paclitaxel—Headache—Niacin—atherosclerosis	0.000108	0.000715	CcSEcCtD
Paclitaxel—Vomiting—Pravastatin—atherosclerosis	0.000108	0.000715	CcSEcCtD
Paclitaxel—Rash—Pravastatin—atherosclerosis	0.000107	0.000709	CcSEcCtD
Paclitaxel—Dermatitis—Pravastatin—atherosclerosis	0.000107	0.000708	CcSEcCtD
Paclitaxel—Headache—Pravastatin—atherosclerosis	0.000106	0.000704	CcSEcCtD
Paclitaxel—Nausea—Niacin—atherosclerosis	0.000103	0.000678	CcSEcCtD
Paclitaxel—Nausea—Pravastatin—atherosclerosis	0.000101	0.000668	CcSEcCtD
Paclitaxel—ABCB1—liver—atherosclerosis	9.56e-05	0.00222	CbGeAlD
Paclitaxel—CYP2C8—Metabolism—APOC3—atherosclerosis	5.64e-06	4.66e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—GSTM1—atherosclerosis	5.63e-06	4.66e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—NOS3—atherosclerosis	5.63e-06	4.66e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—BGN—atherosclerosis	5.63e-06	4.66e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PPARA—atherosclerosis	5.62e-06	4.65e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—LDLR—atherosclerosis	5.6e-06	4.63e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PPARA—atherosclerosis	5.6e-06	4.63e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—MAPK3—atherosclerosis	5.59e-06	4.63e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	5.59e-06	4.62e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—LPL—atherosclerosis	5.58e-06	4.61e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—APOA5—atherosclerosis	5.57e-06	4.61e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ALOX5—atherosclerosis	5.54e-06	4.59e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—ALB—atherosclerosis	5.54e-06	4.58e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—LPL—atherosclerosis	5.53e-06	4.57e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—MTHFR—atherosclerosis	5.52e-06	4.57e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CETP—atherosclerosis	5.47e-06	4.53e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—AGT—atherosclerosis	5.45e-06	4.51e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—GPX1—atherosclerosis	5.44e-06	4.5e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—AGT—atherosclerosis	5.42e-06	4.49e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—INS—atherosclerosis	5.42e-06	4.48e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PPARA—atherosclerosis	5.41e-06	4.48e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	5.41e-06	4.48e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—GPX1—atherosclerosis	5.39e-06	4.46e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	5.36e-06	4.44e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—APOE—atherosclerosis	5.34e-06	4.41e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	5.33e-06	4.41e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—APOE—atherosclerosis	5.31e-06	4.39e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.3e-06	4.39e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CD36—atherosclerosis	5.3e-06	4.38e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—NOS3—atherosclerosis	5.3e-06	4.38e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CAV1—atherosclerosis	5.29e-06	4.37e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—APOA1—atherosclerosis	5.27e-06	4.36e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CAV1—atherosclerosis	5.26e-06	4.35e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.25e-06	4.35e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CD36—atherosclerosis	5.25e-06	4.35e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—APOA1—atherosclerosis	5.25e-06	4.34e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—AGT—atherosclerosis	5.24e-06	4.34e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.24e-06	4.34e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—SCARB1—atherosclerosis	5.24e-06	4.33e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ALOX5—atherosclerosis	5.18e-06	4.28e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PTGS2—atherosclerosis	5.15e-06	4.26e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—APOE—atherosclerosis	5.14e-06	4.25e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.1e-06	4.22e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ABCA1—atherosclerosis	5.09e-06	4.21e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CAV1—atherosclerosis	5.09e-06	4.21e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—APOA1—atherosclerosis	5.08e-06	4.2e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ABCG1—atherosclerosis	5.06e-06	4.18e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—MTHFR—atherosclerosis	5.02e-06	4.15e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—SERPINE1—atherosclerosis	4.98e-06	4.12e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—MTHFR—atherosclerosis	4.98e-06	4.12e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NAMPT—atherosclerosis	4.97e-06	4.11e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—HMGCR—atherosclerosis	4.95e-06	4.09e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—LIPC—atherosclerosis	4.94e-06	4.09e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PPARA—atherosclerosis	4.93e-06	4.08e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—APOC3—atherosclerosis	4.91e-06	4.06e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PPARA—atherosclerosis	4.88e-06	4.04e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—LDLR—atherosclerosis	4.88e-06	4.04e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PTGS2—atherosclerosis	4.85e-06	4.01e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CG—atherosclerosis	4.82e-06	3.98e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CG—atherosclerosis	4.79e-06	3.97e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.78e-06	3.96e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—AGT—atherosclerosis	4.77e-06	3.95e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CETP—atherosclerosis	4.77e-06	3.94e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—FABP4—atherosclerosis	4.75e-06	3.93e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—LCAT—atherosclerosis	4.75e-06	3.93e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NOS3—atherosclerosis	4.75e-06	3.93e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—AGT—atherosclerosis	4.73e-06	3.91e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	4.68e-06	3.87e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—APOE—atherosclerosis	4.67e-06	3.87e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—APOA4—atherosclerosis	4.67e-06	3.86e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PPARG—atherosclerosis	4.65e-06	3.84e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NAMPT—atherosclerosis	4.65e-06	3.84e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CG—atherosclerosis	4.64e-06	3.84e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—APOE—atherosclerosis	4.63e-06	3.83e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CAV1—atherosclerosis	4.63e-06	3.83e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PPARG—atherosclerosis	4.63e-06	3.83e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—APOA1—atherosclerosis	4.62e-06	3.82e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.62e-06	3.82e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—LIPC—atherosclerosis	4.62e-06	3.82e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CAV1—atherosclerosis	4.59e-06	3.8e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—APOC3—atherosclerosis	4.59e-06	3.79e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP7A1—atherosclerosis	4.58e-06	3.79e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—APOA1—atherosclerosis	4.58e-06	3.79e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SCARB1—atherosclerosis	4.57e-06	3.78e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—LDLR—atherosclerosis	4.56e-06	3.77e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—INS—atherosclerosis	4.56e-06	3.77e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—INS—atherosclerosis	4.54e-06	3.75e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PPARG—atherosclerosis	4.48e-06	3.7e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.46e-06	3.69e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CETP—atherosclerosis	4.45e-06	3.68e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ABCA1—atherosclerosis	4.41e-06	3.65e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—INS—atherosclerosis	4.39e-06	3.63e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—HMOX1—atherosclerosis	4.37e-06	3.61e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTGS2—atherosclerosis	4.35e-06	3.6e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—HMGCR—atherosclerosis	4.31e-06	3.57e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SCARB1—atherosclerosis	4.26e-06	3.53e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP27A1—atherosclerosis	4.24e-06	3.51e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	4.23e-06	3.5e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CG—atherosclerosis	4.22e-06	3.49e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—APOB—atherosclerosis	4.18e-06	3.46e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CG—atherosclerosis	4.18e-06	3.46e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ALB—atherosclerosis	4.18e-06	3.46e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ALB—atherosclerosis	4.16e-06	3.44e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.15e-06	3.44e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL6—atherosclerosis	4.09e-06	3.38e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PPARG—atherosclerosis	4.07e-06	3.37e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GSTM1—atherosclerosis	4.07e-06	3.37e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PPARG—atherosclerosis	4.04e-06	3.34e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—HMGCR—atherosclerosis	4.03e-06	3.33e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ALB—atherosclerosis	4.02e-06	3.33e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	4.02e-06	3.32e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—APOA2—atherosclerosis	4.02e-06	3.32e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALOX15—atherosclerosis	4.02e-06	3.32e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	4.02e-06	3.32e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—NOS3—atherosclerosis	4e-06	3.31e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—LPL—atherosclerosis	4e-06	3.31e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—INS—atherosclerosis	3.99e-06	3.3e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—NOS3—atherosclerosis	3.98e-06	3.29e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ABCG5—atherosclerosis	3.97e-06	3.28e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—INS—atherosclerosis	3.96e-06	3.27e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GPX1—atherosclerosis	3.9e-06	3.23e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—NOS3—atherosclerosis	3.85e-06	3.18e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ABCA1—atherosclerosis	3.84e-06	3.18e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—LPA—atherosclerosis	3.83e-06	3.17e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CD36—atherosclerosis	3.8e-06	3.14e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—HMOX1—atherosclerosis	3.78e-06	3.13e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—AKT1—atherosclerosis	3.77e-06	3.12e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—BGN—atherosclerosis	3.71e-06	3.07e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—APOA5—atherosclerosis	3.67e-06	3.04e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ALB—atherosclerosis	3.66e-06	3.03e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTGS2—atherosclerosis	3.66e-06	3.02e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTGS2—atherosclerosis	3.64e-06	3.01e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.63e-06	3.01e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ALB—atherosclerosis	3.63e-06	3e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—APOB—atherosclerosis	3.62e-06	3e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—MTHFR—atherosclerosis	3.6e-06	2.98e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ABCA1—atherosclerosis	3.59e-06	2.97e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	3.54e-06	2.93e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PPARA—atherosclerosis	3.53e-06	2.92e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GSTM1—atherosclerosis	3.53e-06	2.92e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTGS2—atherosclerosis	3.52e-06	2.91e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—NOS3—atherosclerosis	3.5e-06	2.9e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—NOS3—atherosclerosis	3.47e-06	2.87e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—LPL—atherosclerosis	3.46e-06	2.86e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AGT—atherosclerosis	3.42e-06	2.83e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALOX5—atherosclerosis	3.42e-06	2.83e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—STAT3—atherosclerosis	3.39e-06	2.8e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GPX1—atherosclerosis	3.38e-06	2.79e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—APOE—atherosclerosis	3.35e-06	2.77e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CAV1—atherosclerosis	3.32e-06	2.75e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—APOA1—atherosclerosis	3.31e-06	2.74e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—HMOX1—atherosclerosis	3.3e-06	2.73e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CD36—atherosclerosis	3.29e-06	2.72e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MAPK3—atherosclerosis	3.24e-06	2.68e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTGS2—atherosclerosis	3.2e-06	2.65e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTGS2—atherosclerosis	3.17e-06	2.63e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—APOB—atherosclerosis	3.16e-06	2.61e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TGFB1—atherosclerosis	3.14e-06	2.6e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—MTHFR—atherosclerosis	3.12e-06	2.58e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—HMOX1—atherosclerosis	3.08e-06	2.55e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTM1—atherosclerosis	3.07e-06	2.54e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NAMPT—atherosclerosis	3.06e-06	2.53e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PPARA—atherosclerosis	3.06e-06	2.53e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—LIPC—atherosclerosis	3.04e-06	2.52e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—APOC3—atherosclerosis	3.03e-06	2.5e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CG—atherosclerosis	3.02e-06	2.5e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—LPL—atherosclerosis	3.02e-06	2.49e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—LDLR—atherosclerosis	3.01e-06	2.49e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AGT—atherosclerosis	2.96e-06	2.45e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—APOB—atherosclerosis	2.95e-06	2.44e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GPX1—atherosclerosis	2.94e-06	2.43e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CETP—atherosclerosis	2.94e-06	2.43e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PPARG—atherosclerosis	2.92e-06	2.41e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—APOE—atherosclerosis	2.9e-06	2.4e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CAV1—atherosclerosis	2.87e-06	2.38e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTM1—atherosclerosis	2.87e-06	2.37e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—APOA1—atherosclerosis	2.87e-06	2.37e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CD36—atherosclerosis	2.86e-06	2.37e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—INS—atherosclerosis	2.86e-06	2.37e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—LPL—atherosclerosis	2.82e-06	2.33e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SCARB1—atherosclerosis	2.81e-06	2.33e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GPX1—atherosclerosis	2.75e-06	2.27e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—MTHFR—atherosclerosis	2.71e-06	2.25e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CD36—atherosclerosis	2.68e-06	2.21e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PPARA—atherosclerosis	2.66e-06	2.2e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.66e-06	2.2e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ALB—atherosclerosis	2.62e-06	2.17e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CG—atherosclerosis	2.62e-06	2.17e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—AKT1—atherosclerosis	2.59e-06	2.14e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AGT—atherosclerosis	2.58e-06	2.13e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—MTHFR—atherosclerosis	2.54e-06	2.1e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—APOE—atherosclerosis	2.53e-06	2.09e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PPARG—atherosclerosis	2.53e-06	2.09e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—NOS3—atherosclerosis	2.51e-06	2.08e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CAV1—atherosclerosis	2.5e-06	2.07e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—APOA1—atherosclerosis	2.5e-06	2.07e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PPARA—atherosclerosis	2.49e-06	2.06e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—INS—atherosclerosis	2.48e-06	2.05e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—AKT1—atherosclerosis	2.44e-06	2.01e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AGT—atherosclerosis	2.41e-06	1.99e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IL6—atherosclerosis	2.37e-06	1.96e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.37e-06	1.96e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—APOE—atherosclerosis	2.36e-06	1.95e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CAV1—atherosclerosis	2.34e-06	1.94e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—APOA1—atherosclerosis	2.33e-06	1.93e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTGS2—atherosclerosis	2.3e-06	1.9e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CG—atherosclerosis	2.28e-06	1.89e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ALB—atherosclerosis	2.27e-06	1.88e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PPARG—atherosclerosis	2.2e-06	1.82e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—AKT1—atherosclerosis	2.18e-06	1.81e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—NOS3—atherosclerosis	2.17e-06	1.8e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—INS—atherosclerosis	2.16e-06	1.79e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CG—atherosclerosis	2.13e-06	1.76e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PPARG—atherosclerosis	2.06e-06	1.7e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.03e-06	1.68e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—INS—atherosclerosis	2.02e-06	1.67e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTGS2—atherosclerosis	1.99e-06	1.64e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ALB—atherosclerosis	1.98e-06	1.64e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—APOB—atherosclerosis	1.95e-06	1.61e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NOS3—atherosclerosis	1.89e-06	1.57e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.89e-06	1.57e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—LPL—atherosclerosis	1.86e-06	1.54e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ALB—atherosclerosis	1.85e-06	1.53e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—AKT1—atherosclerosis	1.84e-06	1.52e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—AKT1—atherosclerosis	1.83e-06	1.51e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GPX1—atherosclerosis	1.81e-06	1.5e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—AKT1—atherosclerosis	1.77e-06	1.46e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NOS3—atherosclerosis	1.77e-06	1.46e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CD36—atherosclerosis	1.77e-06	1.46e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTGS2—atherosclerosis	1.73e-06	1.43e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.67e-06	1.38e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PPARA—atherosclerosis	1.64e-06	1.36e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.62e-06	1.34e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—AKT1—atherosclerosis	1.61e-06	1.33e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—AKT1—atherosclerosis	1.6e-06	1.32e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AGT—atherosclerosis	1.59e-06	1.31e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—APOE—atherosclerosis	1.56e-06	1.29e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CAV1—atherosclerosis	1.54e-06	1.28e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—APOA1—atherosclerosis	1.54e-06	1.27e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.41e-06	1.16e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PPARG—atherosclerosis	1.36e-06	1.12e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—INS—atherosclerosis	1.33e-06	1.1e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALB—atherosclerosis	1.22e-06	1.01e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NOS3—atherosclerosis	1.17e-06	9.65e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AKT1—atherosclerosis	1.15e-06	9.54e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.07e-06	8.83e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AKT1—atherosclerosis	9.99e-07	8.26e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AKT1—atherosclerosis	8.7e-07	7.2e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AKT1—atherosclerosis	8.13e-07	6.73e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AKT1—atherosclerosis	5.36e-07	4.44e-06	CbGpPWpGaD
